| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
JAK2 V617F mutational status predicts progression to large splenomegaly and leukemic transformation in primary myelofibrosis.
|
Blood
|
2007
|
2.41
|
|
2
|
Cost effectiveness of adjuvant trastuzumab in human epidermal growth factor receptor 2-positive breast cancer.
|
J Clin Oncol
|
2007
|
2.33
|
|
3
|
Practice guidelines for the therapy of essential thrombocythemia. A statement from the Italian Society of Hematology, the Italian Society of Experimental Hematology and the Italian Group for Bone Marrow Transplantation.
|
Haematologica
|
2004
|
2.32
|
|
4
|
Evidence- and consensus-based practice guidelines for the therapy of primary myelodysplastic syndromes. A statement from the Italian Society of Hematology.
|
Haematologica
|
2002
|
1.91
|
|
5
|
A research agenda on the management of intra-abdominal candidiasis: results from a consensus of multinational experts.
|
Intensive Care Med
|
2013
|
1.74
|
|
6
|
Italian Society of Hematology practice guidelines for the management of iron overload in thalassemia major and related disorders.
|
Haematologica
|
2008
|
1.54
|
|
7
|
Consensus conference on the management of tumor lysis syndrome.
|
Haematologica
|
2008
|
1.49
|
|
8
|
A policy for the disposal of autologous hematopoietic progenitor cells: report from an Italian consensus panel.
|
Transfusion
|
2014
|
1.38
|
|
9
|
Practice guidelines for the management of extranodal non-Hodgkin's lymphomas of adult non-immunodeficient patients. Part I: primary lung and mediastinal lymphomas. A project of the Italian Society of Hematology, the Italian Society of Experimental Hematology and the Italian Group for Bone Marrow Transplantation.
|
Haematologica
|
2008
|
1.20
|
|
10
|
The expression of CXCR4 is down-regulated on the CD34+ cells of patients with myelofibrosis with myeloid metaplasia.
|
Blood Cells Mol Dis
|
2007
|
1.12
|
|
11
|
Classical Hodgkin's lymphoma in adults: guidelines of the Italian Society of Hematology, the Italian Society of Experimental Hematology, and the Italian Group for Bone Marrow Transplantation on initial work-up, management, and follow-up.
|
Haematologica
|
2009
|
1.11
|
|
12
|
What reimbursement for coronary revascularization with drug-eluting stents?
|
Eur J Health Econ
|
2004
|
1.09
|
|
13
|
Response criteria for myelofibrosis with myeloid metaplasia: results of an initiative of the European Myelofibrosis Network (EUMNET).
|
Blood
|
2005
|
0.97
|
|
14
|
Apixaban, dabigatran, and rivaroxaban versus warfarin for stroke prevention in non-valvular atrial fibrillation: a cost-effectiveness analysis.
|
Clin Drug Investig
|
2014
|
0.93
|
|
15
|
Circulating CD34+, CD133+, and vascular endothelial growth factor receptor 2-positive endothelial progenitor cells in myelofibrosis with myeloid metaplasia.
|
J Clin Oncol
|
2005
|
0.93
|
|
16
|
Spleen neoangiogenesis in patients with myelofibrosis with myeloid metaplasia.
|
Br J Haematol
|
2004
|
0.92
|
|
17
|
Management of chronic lymphocytic leukemia: practice guidelines from the Italian Society of Hematology, the Italian Society of Experimental Hematology and the Italian Group for Bone Marrow Transplantation.
|
Haematologica
|
2006
|
0.90
|
|
18
|
Management of nodal indolent (non marginal-zone) non-Hodgkin's lymphomas: practice guidelines from the Italian Society of Hematology, Italian Society of Experimental Hematology and Italian Group for Bone Marrow Transplantation.
|
Haematologica
|
2005
|
0.88
|
|
19
|
Clinical management of primary non-acute promyelocytic leukemia acute myeloid leukemia: Practice Guidelines by the Italian Society of Hematology, the Italian Society of Experimental Hematology, and the Italian Group for Bone Marrow Transplantation.
|
Haematologica
|
2008
|
0.87
|
|
20
|
Chronic myeloproliferative disorders.
|
Hematology Am Soc Hematol Educ Program
|
2003
|
0.87
|
|
21
|
SIE, SIES, GITMO evidence-based guidelines on novel agents (thalidomide, bortezomib, and lenalidomide) in the treatment of multiple myeloma.
|
Ann Hematol
|
2012
|
0.87
|
|
22
|
Management of multiple myeloma and related-disorders: guidelines from the Italian Society of Hematology (SIE), Italian Society of Experimental Hematology (SIES) and Italian Group for Bone Marrow Transplantation (GITMO).
|
Haematologica
|
2004
|
0.86
|
|
23
|
Management of nodal diffuse large B-cell lymphomas: practice guidelines from the Italian Society of Hematology, the Italian Society of Experimental Hematology and the Italian Group for Bone Marrow Transplantation.
|
Haematologica
|
2006
|
0.85
|
|
24
|
Thalidomide in myelofibrosis with myeloid metaplasia: a pooled-analysis of individual patient data from five studies.
|
Leuk Lymphoma
|
2002
|
0.84
|
|
25
|
Extracorporeal photopheresis for the treatment of acute and chronic graft-versus-host disease in adults and children: best practice recommendations from an Italian Society of Hemapheresis and Cell Manipulation (SIdEM) and Italian Group for Bone Marrow Transplantation (GITMO) consensus process.
|
Transfusion
|
2013
|
0.82
|
|
26
|
Cancer-related fatigue in Italian cancer patients: validation of the Italian version of the Brief Fatigue Inventory (BFI).
|
Support Care Cancer
|
2012
|
0.81
|
|
27
|
Edoxaban versus warfarin for stroke prevention in non-valvular atrial fibrillation: a cost-effectiveness analysis.
|
J Thromb Thrombolysis
|
2015
|
0.81
|
|
28
|
Optimal use and cost-effectiveness of biologic therapies in inflammatory bowel disease.
|
Intern Emerg Med
|
2011
|
0.80
|
|
29
|
SIE, SIES, GITMO revised guidelines for the management of follicular lymphoma.
|
Am J Hematol
|
2013
|
0.80
|
|
30
|
Best practice for peripheral blood progenitor cell mobilization and collection in adults and children: results of a Società Italiana Di Emaferesi e Manipolazione Cellulare (SIDEM) and Gruppo Italiano Trapianto Midollo Osseo (GITMO) consensus process.
|
Transfusion
|
2011
|
0.79
|
|
31
|
Cost minimization of on-demand maintenance therapy with proton pump inhibitors in nonerosive gastroesophageal reflux disease.
|
Expert Rev Pharmacoecon Outcomes Res
|
2005
|
0.77
|
|
32
|
Overview of alemtuzumab therapy for the treatment of T-cell lymphomas.
|
Leuk Lymphoma
|
2011
|
0.76
|
|
33
|
Screening for factor V Leiden mutation in pregnant women.
|
Lancet
|
2002
|
0.75
|
|
34
|
Constitutional trisomy 8 mosaicism in primary myelofibrosis: relevance to clinical practice and warning for trisomy 8 studies.
|
Cancer Genet Cytogenet
|
2007
|
0.75
|
|
35
|
High prevalence of a screening-detected, HFE-unrelated, mild idiopathic iron overload in Northern Italy.
|
Haematologica
|
2002
|
0.75
|
|
36
|
SIE, SIES, GITMO updated clinical recommendations for the management of chronic lymphocytic leukemia.
|
Leuk Res
|
2011
|
0.75
|
|
37
|
Clinical and economic issues in the treatment of advanced breast cancer with bisphosphonates.
|
Drugs Aging
|
2003
|
0.75
|